Mostrar el registro sencillo del ítem
New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies
dc.contributor.author | Pintus F. | |
dc.contributor.author | Matos M.J. | |
dc.contributor.author | Vilar S. | |
dc.contributor.author | Hripcsak G. | |
dc.contributor.author | Varela C. | |
dc.contributor.author | Uriarte E. | |
dc.contributor.author | Santana L. | |
dc.contributor.author | Borges F. | |
dc.contributor.author | Medda R. | |
dc.contributor.author | Di Petrillo A. | |
dc.contributor.author | Era B. | |
dc.contributor.author | Fais A. | |
dc.date.accessioned | 2020-09-02T22:25:51Z | |
dc.date.available | 2020-09-02T22:25:51Z | |
dc.date.issued | 2017 | |
dc.identifier | 10.1016/j.bmc.2017.01.037 | |
dc.identifier.citation | 25, 5, 1687-1695 | |
dc.identifier.issn | 09680896 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/5811 | |
dc.description | Melanogenesis is a physiological pathway for the formation of melanin. Tyrosinase catalyzes the first step of this process and down-regulation of its activity is responsible for the inhibition of melanogenesis. The search for molecules capable of controlling hyperpigmentation is a trend topic in health and cosmetics. A series of heteroarylcoumarins have been synthesized and evaluated. Compounds 4 and 8 exhibited higher tyrosinase inhibitory activities (IC50= 0.15 and 0.38 μM, respectively), than the reference compound, kojic acid (IC50= 17.9 μM). Compound 4 acts as competitive, while compound 8 as uncompetitive inhibitor of mushroom tyrosinase. Furthermore, compounds 2 and 8 inhibited tyrosinase activity and melanin production in B16F10 cells. In addition, compounds 2–4 and 8 proved to have an interesting antioxidant profile in both ABTS and DPPH radicals scavenging assays. Docking experiments were carried out in order to study the interactions between these heteroarylcoumarins and mushroom tyrosinase. © 2017 Elsevier Ltd | |
dc.language.iso | en | |
dc.publisher | Elsevier Ltd | |
dc.subject | 3-Heteroarylcoumarins | |
dc.subject | B16F10 melanoma cells | |
dc.subject | Melanogenesis | |
dc.subject | Tyrosinase inhibitors | |
dc.subject | 3 (4 bromothiophen 2 yl) 5,7 dihydroxycoumarin | |
dc.subject | 3 (4 bromothiophen 2 yl) 6 methoxycoumarin | |
dc.subject | 3 (4 bromothiophen 2 yl) 7 hydroxycoumarin | |
dc.subject | 3 (4 bromothiophen 2 yl) 7,8 dihydroxycoumarin | |
dc.subject | 3 (4 bromothiophen 2 yl) 8 hydroxycoumarin | |
dc.subject | 3 heteroarylcoumarin derivative | |
dc.subject | 5,7 dihydroxy 3 (thiophen 2 yl)coumarin | |
dc.subject | 6 hydroxy 3 (thiophen 2 yl)coumarin | |
dc.subject | 6 methoxy 3 (thiophen 2 yl)coumarin | |
dc.subject | 7 hydroxy 3 (thiophen 2 yl)coumarin | |
dc.subject | antioxidant | |
dc.subject | coumarin derivative | |
dc.subject | kojic acid | |
dc.subject | trolox C | |
dc.subject | unclassified drug | |
dc.subject | antioxidant | |
dc.subject | enzyme inhibitor | |
dc.subject | melanin | |
dc.subject | monophenol monooxygenase | |
dc.subject | ABTS radical scavenging assay | |
dc.subject | animal cell | |
dc.subject | antimelanogenesis activity | |
dc.subject | antioxidant activity | |
dc.subject | Article | |
dc.subject | controlled study | |
dc.subject | DPPH radical scavenging assay | |
dc.subject | drug activity | |
dc.subject | drug design | |
dc.subject | drug synthesis | |
dc.subject | EC50 | |
dc.subject | IC50 | |
dc.subject | limit of quantitation | |
dc.subject | molecular docking | |
dc.subject | molecular model | |
dc.subject | mouse | |
dc.subject | nonhuman | |
dc.subject | animal | |
dc.subject | antagonists and inhibitors | |
dc.subject | biosynthesis | |
dc.subject | carbon nuclear magnetic resonance | |
dc.subject | mass spectrometry | |
dc.subject | proton nuclear magnetic resonance | |
dc.subject | tumor cell line | |
dc.subject | Animals | |
dc.subject | Antioxidants | |
dc.subject | Carbon-13 Magnetic Resonance Spectroscopy | |
dc.subject | Cell Line, Tumor | |
dc.subject | Enzyme Inhibitors | |
dc.subject | Mass Spectrometry | |
dc.subject | Melanins | |
dc.subject | Mice | |
dc.subject | Models, Molecular | |
dc.subject | Molecular Docking Simulation | |
dc.subject | Monophenol Monooxygenase | |
dc.subject | Proton Magnetic Resonance Spectroscopy | |
dc.title | New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies | |
dc.type | Article |